News for Sangamo BioSciences, Inc. (SGMO)

News for Sangamo BioSciences, Inc.
Date Headline
Dec 14, 2017 09:00 AM Why Sangamo Therapeutics (SGMO) Could Be Positioned for a Surge
Dec 07, 2017 04:22 PM Sangamo Announces European Medicines Agency Recommendation Of Orphan Medicinal Product Designation For Investigational Genome Editing Treatments For MPS I And MPS II
Dec 06, 2017 09:07 AM The Zacks Analyst Blog Highlights: Sangamo Therapeutics, Sarepta Therapeutics, Akebia Therapeutics, Calithera Biosciences and GlycoMimetics
Dec 05, 2017 01:18 PM ETFs with exposure to Sangamo Therapeutics, Inc. : December 5, 2017
Dec 04, 2017 09:32 AM 3 Stocks That Quadrupled
Dec 01, 2017 08:25 AM Sangamo Therapeutics, Inc. :SGMO-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017
Nov 30, 2017 03:58 PM Here's Why Sangamo Therapeutics Rose as Much as 14.9% Thursday
Nov 24, 2017 02:35 PM Who Are The Top Investors In Sangamo Therapeutics Inc (SGMO)?
Nov 24, 2017 01:01 PM Sangamo Therapeutics, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Nov 22, 2017 01:08 PM The 3 Stocks on the MFM Team's Radar This Week